 TORONTO--BUSINESS WIRE--- HUGE FSDPharma--FSD Pharma Inc. NASDAQ: HUGE CSE: HUGE FRA: 0K9A FSD Pharma or the Company, a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that Anthony Durkacz, Interim CEO of FSD Pharma, will present at the H.C. Wainwright Bioconnect Conference to be held virtually on January 10-13, 2022. Mr. Durkaczs presentation will be available on-demand for conference attendees starting at 7:00 a.m. ET on January 10 